Canadian Cancer Trials Group

This study is testing whether adding two oral drugs (sonrotoclax and zanubrutinib) to a standard cell therapy (CAR-T) can better control a type of blood cancer called mantle cell lymphoma that has returned or stopped responding to prior treatments. It will enroll 40 adults who ar…

This early-stage study is testing a new type of personalized immune cell therapy called GCAR1 in people with advanced cancers that have stopped responding to standard treatments. The main goal is to find the safest and most effective dose of GCAR1 for patients with specific types…

This study is not testing a new treatment. Instead, it aims to collect and store tumor tissue and blood samples from about 120 Canadian cancer patients who are receiving or have received immunotherapy. Researchers will use these samples to study why some patients respond well to …

This study aims to understand if cancer patients are willing to share information about their social and economic backgrounds during clinical trials. Researchers will ask 1,000 participants about factors like income, education, housing, and experiences with discrimination. The go…